It was an unusual year for the Scrip 100 rankings as revenues from the sale of vaccines and treatments for COVID-19 skewed the leaderboard in ways that could not have been anticipated before the virus emerged in 2020 and sparked a global health crisis.
Pfizer Leads An Unusual Year For The Scrip 100
Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.
